Sign Up Today and Learn More About Genalyte Stock
Invest in or calculate the value of your shares in Genalyte or other pre-IPO companies through EquityZen's platform.
Genalyte Stock (GENL)
Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
About Genalyte Stock
Founded
2007
Headquarters
San Diego, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Genalyte Press Mentions
Stay in the know about the latest news on Genalyte
Rapid multiplexed serological test
patents • Apr 14, 2024
Genalyte Expands Laboratory Services Offering with Acquisition of BaseHealth
pharmiweb • Apr 26, 2020
Other Blood Testing Cos. Avoid Taint of Theranos
sdbj • Jul 20, 2018
Other Blood Testing Cos. Avoid Taint of Theranos
sdbj • Jul 16, 2018
“Like Theranos, but it works”–health startup Genalyte proves its worth
fastcompany • Jun 13, 2018
Genalyte Management
Leadership team at Genalyte
Chief Financial Officer
Ian Wisenberg
Board of Directors
Bradford C. Webb, PhD
Join now and verify your accreditation status to gain access to:
- Genalyte current valuation
- Genalyte stock price
- Available deals in Genalyte and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Genalyte Stock
How to invest in Genalyte stock?
Accredited investors can buy pre-IPO stock in companies like Genalyte through EquityZen funds. These investments are made available by existing Genalyte shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Genalyte stock?
Shareholders can sell their Genalyte stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
